Personalised medicine has, over recent years, made the transition from ambition to reality. It moves healthcare from taking a one-size-fits-all or blunt approach to something far more responsive and tailored.
It is not hyperbolic to say that the world is at war – and the enemy is a virus. Governments, medics, scientists, policymakers, businesses and individuals alike are racing to develop the most effective means of battling COVID-19. Biotechnology innovation and artificial intelligence (AI) are critical elements in this race.